232 related articles for article (PubMed ID: 34492627)
41. MRI-Based Radiomics Methods for Predicting Ki-67 Expression in Breast Cancer: A Systematic Review and Meta-analysis.
Tabnak P; HajiEsmailPoor Z; Baradaran B; Pashazadeh F; Aghebati Maleki L
Acad Radiol; 2024 Mar; 31(3):763-787. PubMed ID: 37925343
[TBL] [Abstract][Full Text] [Related]
42. [Preliminary study of combining T2-weighted imaging, diffusion weighted imaging and dynamic contrast enhanced-magnetic resonance imaging for diagnosing prostatic central gland cancer].
Li P; Yang W; Chen Z; Guo Y; Cai L; Du Y; Li Y
Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(31):2448-51. PubMed ID: 25400054
[TBL] [Abstract][Full Text] [Related]
43. Value of diffusion-weighted MRI in predicting early response to neoadjuvant chemotherapy of breast cancer: comparison between ROI-ADC and whole-lesion-ADC measurements.
Hottat NA; Badr DA; Lecomte S; Besse-Hammer T; Jani JC; Cannie MM
Eur Radiol; 2022 Jun; 32(6):4067-4078. PubMed ID: 35015127
[TBL] [Abstract][Full Text] [Related]
44. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
[TBL] [Abstract][Full Text] [Related]
46. Combination of DCE-MRI and NME-DWI via Deep Neural Network for Predicting Breast Cancer Molecular Subtypes.
Ba ZC; Zhang HX; Liu AY; Zhou XX; Liu L; Wang XY; Nanding A; Sang XQ; Kuai ZX
Clin Breast Cancer; 2024 Jul; 24(5):e417-e427. PubMed ID: 38555225
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging for malignant ovarian tumors: a systematic review and meta-analysis.
Wei M; Bo F; Cao H; Zhou W; Shan W; Bai G
Acta Radiol; 2021 Jul; 62(7):966-978. PubMed ID: 32741199
[TBL] [Abstract][Full Text] [Related]
48. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC).
Abdelhafez AH; Musall BC; Adrada BE; Hess K; Son JB; Hwang KP; Candelaria RP; Santiago L; Whitman GJ; Le-Petross HT; Moseley TW; Arribas E; Lane DL; Scoggins ME; Leung JWT; Mahmoud HS; White JB; Ravenberg EE; Litton JK; Valero V; Wei P; Thompson AM; Moulder SL; Pagel MD; Ma J; Yang WT; Rauch GM
Breast Cancer Res Treat; 2021 Jan; 185(1):1-12. PubMed ID: 32920733
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic Accuracy of MRI for Detecting Cervical Invasion in Patients with Endometrial Carcinoma: A Meta-Analysis.
Bi Q; Bi G; Wang J; Zhang J; Li H; Gong X; Ren L; Wu K
J Cancer; 2021; 12(3):754-764. PubMed ID: 33403033
[No Abstract] [Full Text] [Related]
50. Assessment of breast mass morphology with diffusion-weighted MRI: Beyond apparent diffusion coefficient.
Kul S; Metin Y; Kul M; Metin N; Eyuboglu I; Ozdemir O
J Magn Reson Imaging; 2018 Dec; 48(6):1668-1677. PubMed ID: 29734493
[TBL] [Abstract][Full Text] [Related]
51. Additional value of diffusion-weighted imaging to evaluate multifocal and multicentric breast cancer detected using pre-operative breast MRI.
Song SE; Park EK; Cho KR; Seo BK; Woo OH; Jung SP; Cho SB
Eur Radiol; 2017 Nov; 27(11):4819-4827. PubMed ID: 28593433
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic value of diffusion-weighted imaging with synthetic b-values in breast tumors: comparison with dynamic contrast-enhanced and multiparametric MRI.
Daimiel Naranjo I; Lo Gullo R; Saccarelli C; Thakur SB; Bitencourt A; Morris EA; Jochelson MS; Sevilimedu V; Martinez DF; Pinker-Domenig K
Eur Radiol; 2021 Jan; 31(1):356-367. PubMed ID: 32780207
[TBL] [Abstract][Full Text] [Related]
53. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.
Napoletano M; Mazzucca D; Prosperi E; Aisa MC; Lupattelli M; Aristei C; Scialpi M
Abdom Radiol (NY); 2019 Nov; 44(11):3664-3673. PubMed ID: 31004202
[TBL] [Abstract][Full Text] [Related]
54. Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer.
Kim Y; Kim SH; Song BJ; Kang BJ; Yim KI; Lee A; Nam Y
Korean J Radiol; 2018; 19(4):682-691. PubMed ID: 29962874
[TBL] [Abstract][Full Text] [Related]
55. Multi-parametric magnetic resonance imaging characterization of orbital lesions: a triple blind study.
Russo C; Strianese D; Perrotta M; Iuliano A; Bernardo R; Romeo V; Ugga L; Brunetti L; Tranfa F; Elefante A
Semin Ophthalmol; 2020 Feb; 35(2):95-102. PubMed ID: 32298217
[No Abstract] [Full Text] [Related]
56. Lymphoma and inflammation in the orbit: Diagnostic performance with diffusion-weighted imaging and dynamic contrast-enhanced MRI.
Sun B; Song L; Wang X; Li J; Xian J; Wang F; Tan P
J Magn Reson Imaging; 2017 May; 45(5):1438-1445. PubMed ID: 27649521
[TBL] [Abstract][Full Text] [Related]
57. Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings.
Sharma U; Agarwal K; Hari S; Mathur SR; Seenu V; Parshad R; Jagannathan NR
Magn Reson Imaging; 2019 Sep; 61():66-72. PubMed ID: 31128225
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic performance of diffusion-weighted imaging for differentiating benign and malignant gallbladder lesions: A systematic review and meta-analysis.
You MW; Yun SJ
J Magn Reson Imaging; 2018 Nov; 48(5):1375-1388. PubMed ID: 29676860
[TBL] [Abstract][Full Text] [Related]
59. Predictive value of T2-weighted imaging and dynamic contrast-enhanced MRI for assessing cervical invasion in patients with endometrial cancer: a meta-analysis.
Bi Q; Chen Y; Chen J; Zhang H; Lei Y; Yang J; Zhang Y; Bi G
Clin Imaging; 2021 Oct; 78():206-213. PubMed ID: 34049140
[TBL] [Abstract][Full Text] [Related]
60. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Hsiang DJ; Yamamoto M; Mehta RS; Su MY; Baick CH; Lane KT; Butler JA
Arch Surg; 2007 Sep; 142(9):855-61; discussion 860-1. PubMed ID: 17875840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
